{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:39:28Z","timestamp":1790008768599,"version":"4.0.1"},"reference-count":179,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T00:00:00Z","timestamp":1662940800000},"content-version":"vor","delay-in-days":5124,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.fertnstert.2007.07.1298","type":"journal-article","created":{"date-parts":[[2007,11,26]],"date-time":"2007-11-26T12:14:19Z","timestamp":1196079259000},"page":"642-672","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Effects of non-oral postmenopausal hormone therapy on markers of cardiovascular risk: a systematic review"],"prefix":"10.1016","volume":"90","author":[{"given":"Majoie","family":"Hemelaar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius J.","family":"van der Mooren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandana","family":"Rad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis","family":"Kluft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kenemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2007.07.1298_bib1","doi-asserted-by":"crossref","first-page":"447","DOI":"10.7326\/0003-4819-85-4-447","article-title":"Menopause and risk of cardiovascular disease: the Framingham study","volume":"85","author":"Kannel","year":"1976","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib2","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJM199109123251102","article-title":"Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study","volume":"325","author":"Stampfer","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1146\/annurev.publhealth.19.1.55","article-title":"Hormone replacement therapy, heart disease, and other considerations","volume":"19","author":"Barrett-Connor","year":"1998","journal-title":"Annu Rev Public Health"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib4","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0378-5122(90)90012-U","article-title":"Influence of menopause on serum lipids and lipoproteins","volume":"12","author":"Jensen","year":"1990","journal-title":"Maturitas"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib5","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3109\/09513599909167545","article-title":"Postmenopausal hormone replacement, risk estimators for coronary artery disease and cardiovascular protection","volume":"13","author":"Mijatovic","year":"1999","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib6","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0015-0282(01)01699-5","article-title":"Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein(a) concentrations: analysis of studies published from 1974\u20132000","volume":"75","author":"Godsland","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib7","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen\/progestin Replacement Study (HERS) Research Group","volume":"280","author":"Hulley","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/jama.288.1.49","article-title":"Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen\/progestin Replacement Study follow-up (HERS II)","volume":"288","author":"Grady","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial","volume":"288","author":"Writing Group for the Women's Health Initiative Investigators","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib10","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa030808","article-title":"Estrogen plus progestin and the risk of coronary heart disease","volume":"349","author":"Manson","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib11","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial","volume":"291","author":"Anderson","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib12","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(02)12001-0","article-title":"Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial","volume":"360","author":"Cherry","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib13","first-page":"595","article-title":"Thrombotic risk during pregnancy: a population study","volume":"94","author":"Lindqvist","year":"1999","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib14","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-143-10-200511150-00006","article-title":"Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study","volume":"143","author":"Heit","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib15","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/bmj.2.5703.203","article-title":"Thromboembolic disease and the steroidal content of oral contraceptives. A report to the Committee on Safety of Drugs","volume":"2","author":"Inman","year":"1970","journal-title":"Br Med J"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib16","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0140-6736(95)91927-9","article-title":"Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease","volume":"346","author":"World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib17","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1056\/NEJM200105173442007","article-title":"Oral contraceptives and the risk of venous thrombosis","volume":"344","author":"Vandenbroucke","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib18","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0140-6736(96)07113-9","article-title":"Risk of venous thromboembolism in users of hormone replacement therapy","volume":"348","author":"Daly","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib19","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(96)07308-4","article-title":"Prospective study of exogenous hormones and risk of pulmonary embolism in women","volume":"348","author":"Grodstein","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib20","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.1995.03520270033028","article-title":"Effects of estrogen or estrogen\/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen\/Progestin Interventions (PEPI) Trial","volume":"273","author":"The Writing Group for the PEPI Trial","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib21","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1365-2265.1997.2601068.x","article-title":"Mortality and morbidity in transsexual subjects treated with cross-sex hormones","volume":"47","author":"van Kesteren","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib22","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(03)14066-4","article-title":"Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk","volume":"362","author":"Scarabin","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib23","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1161\/CIRCULATIONAHA.105.565556","article-title":"Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration","volume":"112","author":"Straczek","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib24","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/j.1471-0528.2002.01544.x","article-title":"A study of hormone replacement therapy in postmenopausal women with ischaemic heart disease: the Papworth HRT atherosclerosis study","volume":"109","author":"Clarke","year":"2002","journal-title":"BJOG"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0378-5122(90)90003-O","article-title":"Pharmacokinetics of oestrogens and progestogens","volume":"12","author":"Kuhl","year":"1990","journal-title":"Maturitas"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib26","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0378-5122(89)90024-8","article-title":"Comparative metabolic study of percutaneous versus oral micronized 17 beta-oestradiol in replacement therapy","volume":"11","author":"Faguer de Moustier","year":"1989","journal-title":"Maturitas"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib27","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1055\/s-0038-1642453","article-title":"The effects of transdermal estradiol and oral conjugated estrogens on haemostasis variables","volume":"71","author":"Kroon","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib28","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0049-3848(97)00003-0","article-title":"Effects of estrogen replacement therapy on thrombin generation","volume":"85","author":"Pinto","year":"1997","journal-title":"Thromb Res"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib29","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0015-0282(97)81910-3","article-title":"Endothelin levels decrease after oral and nonoral estrogen in postmenopausal women with increased cardiovascular risk factors","volume":"67","author":"Wilcox","year":"1997","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib30","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1055\/s-0037-1614850","article-title":"Elevated levels of sE-selectin in post-menopausal females are decreased by hormone replacement therapy to levels observed in pre-menopausal females","volume":"82","author":"Kennedy","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib31","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1046\/j.1365-2796.2000.00648.x","article-title":"Increased plasma concentrations of TGF-beta1 after hormone replacement therapy","volume":"247","author":"Djurovic","year":"2000","journal-title":"J Intern Med"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0049-3848(99)00233-9","article-title":"The effects of hormone replacement therapy on hemostatic variables in women with angiographically verified coronary artery disease: results from the estrogen in women with atherosclerosis study","volume":"98","author":"H\u00f8ibraaten","year":"2000","journal-title":"Thromb Res"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib33","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0021-9150(99)00318-4","article-title":"Insulin-like growth factor binding protein-1 (IGFBP-1) and IGF-I during oral and transdermal estrogen replacement therapy: relation to lipoprotein(a) levels","volume":"149","author":"Paassilta","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib34","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1046\/j.1463-1326.2000.00087.x","article-title":"Plasma endothelin in postmenopausal women with type 2 diabetes mellitus and metabolic syndrome: a comparison of oral combined and transdermal oestrogen-only replacement therapy","volume":"2","author":"Saltevo","year":"2000","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib35","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/fampra\/17.6.497","article-title":"The effect of hormone replacement therapy and route of administration on selected cardiovascular risk factors in post-menopausal women","volume":"17","author":"Seed","year":"2000","journal-title":"Fam Pract"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib36","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1055\/s-0037-1613947","article-title":"Reduced expression of endothelial cell markers after long-term transdermal hormone replacement therapy in women with coronary artery disease","volume":"83","author":"Seljeflot","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib37","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1055\/s-0037-1615643","article-title":"Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women","volume":"85","author":"Vehkavaara","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib38","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1055\/s-0037-1613263","article-title":"Effects of transdermal and oral oestrogen replacement therapy on C-reactive protein levels in postmenopausal women: a randomised, placebo-controlled trial","volume":"88","author":"Post","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib39","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/S0735-1097(02)02565-2","article-title":"Oral conjugated equine estrogen increases plasma von Willebrand factor in postmenopausal women","volume":"40","author":"Rabbani","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib40","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0378-5122(02)00319-5","article-title":"Endothelin-1 and nitric oxide levels are related to cardiovascular risk factors but are not modified by estradiol replacement in healthy postmenopausal women. A cross-sectional and a randomized cross-over study","volume":"44","author":"Cagnacci","year":"2003","journal-title":"Maturitas"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib41","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/01.GME.0000064866.58809.E5","article-title":"Oral, more than transdermal, estrogen therapy improves lipids and lipoprotein(a) in postmenopausal women: a randomized, placebo-controlled study","volume":"10","author":"Hemelaar","year":"2003","journal-title":"Menopause"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib42","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1161\/01.ATV.0000074146.36646.C8","article-title":"Effect of oral and transdermal estrogen replacement therapy on hemostatic variables associated with venous thrombosis: a randomized, placebo-controlled study in postmenopausal women","volume":"23","author":"Post","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib43","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1067\/S0002-9378(03)00599-4","article-title":"Effects of low-dose oral and transdermal estrogen replacement therapy on hemostatic factors in healthy postmenopausal women: a randomized placebo-controlled study","volume":"189","author":"Post","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib44","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0015-0282(02)04661-7","article-title":"A randomized placebo-controlled study of the effect of transdermal vs. oral estradiol with or without gestodene on homocysteine levels","volume":"79","author":"Smolders","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib45","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0735-1097(03)00156-6","article-title":"Differential effects of oral versus transdermal estrogen replacement therapy on C-reactive protein in postmenopausal women","volume":"41","author":"Vongpatanasin","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib46","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0021-9150(03)00088-1","article-title":"Double blind, randomized study of estradiol replacement therapy on markers of inflammation, coagulation and fibrinolysis","volume":"168","author":"\u017degura","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib47","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/01.GME.0000153888.94399.AF","article-title":"Effects of transdermal and oral postmenopausal hormone therapy on vascular function: a randomized, placebo-controlled study in healthy postmenopausal women","volume":"12","author":"Hemelaar","year":"2005","journal-title":"Menopause"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib48","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.maturitas.2004.03.011","article-title":"Transdermal estradiol does not impair hemostatic biomarkers in postmenopausal women","volume":"50","author":"Mart\u00ednez","year":"2005","journal-title":"Maturitas"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib49","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1210\/jc.2004-0727","article-title":"Levels of serum C-reactive protein during oral and transdermal estradiol in postmenopausal women with and without a history of intrahepatic cholestasis of pregnancy","volume":"90","author":"Ropponen","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib50","first-page":"12","article-title":"Effect of norethisterone acetate on markers of inflammation in postmenopausal women receiving estradiol","volume":"14","author":"\u017degura","year":"2005","journal-title":"Gynaecol Perinatol Suppl"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib51","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2796.2005.01602.x","article-title":"Oral, more than transdermal, oestrogen therapy lowers asymmetric dimethylarginine in healthy postmenopausal women: a randomized, placebo-controlled study","volume":"259","author":"Verhoeven","year":"2006","journal-title":"J Intern Med"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib52","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0015-0282(98)00028-4","article-title":"The long-term effects of oral and transdermal postmenopausal hormone replacement therapy on nitric oxide, endothelin-1, prostacyclin, and thromboxane","volume":"69","author":"Ylikorkala","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib53","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0378-5122(00)00164-X","article-title":"Postmenopause hormone treatment in women with NIDDM or impaired glucose tolerance: the MEDIA randomized clinical trial","volume":"37","author":"Cornu","year":"2000","journal-title":"Maturitas"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib54","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0015-0282(00)01623-X","article-title":"Failure of the combination of sequential oral and transdermal estradiol plus norethisterone acetate to affect plasma homocysteine levels","volume":"74","author":"Evi\u00f6","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib55","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0168-8227(01)00297-2","article-title":"Glycaemic control and plasma lipoproteins in menopausal women with Type 2 diabetes treated with oral and transdermal combined hormone replacement therapy","volume":"54","author":"Darko","year":"2001","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib56","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0378-5122(01)00300-0","article-title":"Positive effects on cardiovascular and breast metabolic markers of oral estradiol and dydrogesterone in comparison with transdermal estradiol and norethisterone acetate","volume":"41","author":"Campagnoli","year":"2002","journal-title":"Maturitas"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib57","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0002-9149(03)00542-3","article-title":"Differing effects of oral and transdermal hormone replacement therapy on cardiovascular risk factors in healthy postmenopausal women","volume":"92","author":"Strandberg","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib58","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.fertnstert.2003.05.026","article-title":"Comparison of the effect of oral and transdermal hormone therapy on fasting and postmethionine homocysteine levels","volume":"81","author":"Cagnacci","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib59","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1365-2141.2004.04846.x","article-title":"Randomized trial of effect of transdermal continuous combined hormone replacement therapy on cardiovascular risk markers","volume":"124","author":"Stevenson","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib60","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.maturitas.2004.10.001","article-title":"Lipids and clotting factors during low dose transdermal estradiol\/norethisterone use","volume":"50","author":"Brynhildsen","year":"2005","journal-title":"Maturitas"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib61","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/BF00314984","article-title":"Cyclic hormonal replacement therapy after the menopause: transdermal versus oral treatment","volume":"41","author":"Cortellaro","year":"1991","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib62","first-page":"639","article-title":"Influence of hormonal replacement therapy on AT III in climacteric women","volume":"113","author":"Enzelsberger","year":"1991","journal-title":"Zentralbl Gynakol"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib63","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0378-5122(95)00920-G","article-title":"Influence of two hormone replacement therapy regimens, oral oestradiol valerate and cyproterone acetate versus transdermal oestradiol and oral dydrogesterone, on lipid metabolism","volume":"22","author":"Schram","year":"1995","journal-title":"Maturitas"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib64","first-page":"3384","article-title":"Postmenopausal hormonal replacement decreases plasma levels of endothelin-1","volume":"80","author":"Ylikorkala","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib65","first-page":"540","article-title":"Estrogen replacement in postmenopause, blood coagulation and fibrinolysis: comparison of a new kind of transdermal estradiol treatment with oral therapy with conjugated estrogens","volume":"117","author":"Winkler","year":"1995","journal-title":"Zentralbl Gynakol"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib66","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1055\/s-0038-1650300","article-title":"Effects on haemostasis of hormone replacement therapy with transdermal estradiol and oral sequential medroxyprogesterone acetate: a 1-year, double-blind, placebo-controlled study","volume":"75","author":"The Writing Group for the Estradiol Clotting Factors Study","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib67","first-page":"509","article-title":"Effect of oral and transdermal hormone replacement therapy on lipid profile and Lp(a) level in menopausal women with hypercholesterolemia","volume":"41","author":"Perrone","year":"1996","journal-title":"Int J Fertil Menopausal Stud"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib68","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1161\/01.ATV.16.10.1215","article-title":"Hormone replacement therapy lowers plasma Lp(a) concentrations. Comparison of cyclic transdermal and continuous estrogen-progestin regimens","volume":"16","author":"Taskinen","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib69","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1471-0528.1997.tb11982.x","article-title":"Long-term influence of different postmenopausal hormone replacement regimens on serum lipids and lipoprotein(a): a randomised study","volume":"104","author":"H\u00e4nggi","year":"1997","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib70","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1161\/01.ATV.17.11.3071","article-title":"Effects of oral and transdermal estrogen\/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial","volume":"17","author":"Scarabin","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib71","first-page":"330","article-title":"Effect of estrogen-progestin hormonal replacement therapy on plasma antithrombin III of postmenopausal women","volume":"77","author":"Bonduki","year":"1998","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib72","first-page":"157","article-title":"Effects of oral and transdermal hormone replacement therapy on lipoprotein(a) and lipids: a randomized controlled trial","volume":"5","author":"Meschia","year":"1998","journal-title":"Menopause"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib73","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3109\/09513599909167556","article-title":"Decrease of serum endothelin levels with postmenopausal hormone replacement therapy or tibolone","volume":"13","author":"H\u00e4nggi","year":"1999","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib74","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0895-7061(99)00074-6","article-title":"Double-blind randomized placebo-controlled study of transdermal estrogen replacement therapy on hypertensive postmenopausal women","volume":"12","author":"Modena","year":"1999","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib75","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0140-6736(99)02079-6","article-title":"Hormone replacement therapy and sensitive C-reactive protein concentrations in women with type-2 diabetes","volume":"354","author":"Sattar","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib76","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1055\/s-0037-1614551","article-title":"Hormone replacement therapy and circulating ICAM-1 in postmenopausal women\u2014a randomised controlled trial","volume":"81","author":"Scarabin","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib77","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/j.1471-0528.1999.tb08435.x","article-title":"A randomised comparison of the effects of oral versus transdermal 17(beta)-oestradiol, each combined with sequential oral norethisterone acetate, on serum lipoprotein levels","volume":"106","author":"Spencer","year":"1999","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib78","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0378-5122(01)00196-7","article-title":"Effects of hormonal replacement therapy in postmenopausal hypertensive patients","volume":"40","author":"Affinito","year":"2001","journal-title":"Maturitas"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib79","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00042192-200109000-00009","article-title":"Comparison of transdermal and oral estrogen-progestin replacement therapy: effects on cardiovascular risk factors","volume":"8","author":"Chen","year":"2001","journal-title":"Menopause"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib80","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1055\/s-0037-1616121","article-title":"The effects of transdermal and oral estrogen\/progesterone regimens on free and total protein S in postmenopausal women","volume":"86","author":"Marque","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib81","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1210\/jcem.86.3.7297","article-title":"The effects of transdermal estradiol in combination with oral norethisterone on lipoproteins, coagulation, and endothelial markers in postmenopausal women with type 2 diabetes: a randomized, placebo-controlled study","volume":"86","author":"Perera","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib82","first-page":"262","article-title":"The effects of oral or transdermal 17(beta)-oestradiol combined with cyclical oral Norethisterone acetate on serum lipoprotein concentrations","volume":"28","author":"Tejerizo-Lopez","year":"2001","journal-title":"Clin Invest Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib83","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1161\/01.CIR.0000028463.74880.EA","article-title":"Effect of transdermal estradiol and oral conjugated estrogen on C-reactive protein in retinoid-placebo trial in healthy women","volume":"106","author":"Decensi","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib84","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000064667","article-title":"Hormone replacement therapy does not affect plasma homocysteine in postmenopausal women with coronary artery disease. Free tissue factor pathway inhibitor antigen, a circulating anticoagulant, is related to plasma homocysteine","volume":"98","author":"Os","year":"2002","journal-title":"Cardiology"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib85","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1053\/meta.2002.35584","article-title":"Simvastatin, transdermal patch, and oral estrogen-progestogen preparation in early-postmenopausal hypercholesterolemic women: a randomized, placebo-controlled clinical trial","volume":"51","author":"Vigna","year":"2002","journal-title":"Metabolism"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib86","first-page":"70","article-title":"Influence of estrogen replacement therapy on atherogenic profile in postmenopausal women","volume":"20","author":"Cano","year":"2003","journal-title":"An Med Interna"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib87","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/01.GME.0000054762.94658.B4","article-title":"Long-term effects of oral and transdermal hormone replacement therapy on plasma homocysteine levels","volume":"10","author":"Chiantera","year":"2003","journal-title":"Menopause"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib88","first-page":"114","article-title":"Repercussions of hormone replacement therapy in the coagulation system","volume":"60","author":"Ferrer","year":"2003","journal-title":"Acta Ginecol"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib89","doi-asserted-by":"crossref","first-page":"346","DOI":"10.5414\/CPP41346","article-title":"Effects of transdermal and oral estrogen supplementation on endothelial function, inflammation and cellular redox state","volume":"41","author":"Kawano","year":"2003","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib90","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1055\/s-0037-1613608","article-title":"Differential effects of oral and transdermal postmenopausal estrogen replacement therapies on C-reactive protein","volume":"90","author":"Lacut","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib91","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/01.ATV.0000087141.05044.1F","article-title":"Differential effects of oral and transdermal estrogen\/progesterone regimens on sensitivity to activated protein C among postmenopausal women: a randomized trial","volume":"23","author":"Oger","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib92","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.maturitas.2003.08.005","article-title":"Effect of oral or transdermal hormone replacement therapy on homocysteine levels: a randomized clinical trial","volume":"48","author":"Bruschi","year":"2004","journal-title":"Maturitas"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib93","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.atherosclerosis.2004.01.021","article-title":"Effects of oral and transdermal 17 beta-estradiol combined with progesterone on homocysteine metabolism in postmenopausal women: a randomised placebo-controlled trial","volume":"174","author":"Lacut","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib94","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.metabol.2004.07.015","article-title":"Does the type of hormone replacement therapy affect lipoprotein(a), homocysteine, and C-reactive protein levels in postmenopausal women?","volume":"54","author":"Bukowska","year":"2005","journal-title":"Metabolism"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib95","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.maturitas.2005.01.004","article-title":"The effects of oral and transdermal hormone replacement therapy on C-reactive protein levels and other inflammatory markers in women with high risk of thrombosis","volume":"52","author":"Eilertsen","year":"2005","journal-title":"Maturitas"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib96","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.maturitas.2004.09.002","article-title":"Intranasal 17beta-estradiol treatment and Vitamin B12, folate and homocysteine in menopause","volume":"50","author":"Harma","year":"2005","journal-title":"Maturitas"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib97","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000088603","article-title":"Effect of pulsed estrogen therapy on hemostatic markers in comparison with oral estrogen regimen in postmenopausal women","volume":"61","author":"Basurto","year":"2006","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib98","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.fertnstert.2005.09.036","article-title":"Intranasal continuous combined 17beta-estradiol\/norethisterone therapy improves the lipid profile in healthy postmenopausal women","volume":"85","author":"Hemelaar","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib99","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/humrep\/del034","article-title":"No increase in C-reactive protein levels during intranasal compared to oral hormone therapy in healthy post-menopausal women","volume":"21","author":"Hemelaar","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib100","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1161\/01.ATV.0000224325.96659.53","article-title":"Less effect of intranasal than oral hormone therapy on factors associated with venous thrombosis risk in healthy postmenopausal women","volume":"26","author":"Hemelaar","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib101","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1067\/mob.2000.104843","article-title":"Clinical equivalence of intranasal and oral 17beta-estradiol for postmenopausal symptoms","volume":"182","author":"Mattsson","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib102","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/0002-9378(82)90468-9","article-title":"Effects of percutaneous estradiol and conjugated estrogens on the level of plasma proteins and triglycerides in postmenopausal women","volume":"143","author":"Elkik","year":"1982","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib103","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1177\/107602960200800307","article-title":"Acute effects of transdermal 17beta-estradiol on hemostatic variables after 24-hour treatment","volume":"8","author":"Hognert","year":"2002","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib104","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1136\/ard.53.1.54","article-title":"Effects of hormone replacement therapy in rheumatoid arthritis: a double blind placebo-controlled study","volume":"53","author":"MacDonald","year":"1994","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib105","first-page":"92","article-title":"Fibrinolysis and lipoprotein(a) in women with coronary artery disease. Influence of hormone replacement therapy","volume":"86","author":"Falco","year":"2001","journal-title":"Haematologica"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib106","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1053\/euhj.2001.2631","article-title":"Acute and mid-term combined hormone replacement therapy improves endothelial function in post-menopausal women with angina and angiographically normal coronary arteries","volume":"22","author":"Sitges","year":"2001","journal-title":"Eur Heart J"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib107","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/S0015-0282(02)04285-1","article-title":"Effects of vaginally administered high estradiol doses on hormonal pharmacokinetics and hemostasis in postmenopausal women","volume":"78","author":"Hall","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib108","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0378-5122(99)00021-3","article-title":"Absorption and bioavailability of oestradiol from a gel, a patch and a tablet","volume":"32","author":"Jarvinen","year":"1999","journal-title":"Maturitas"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib109","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0378-5122(01)00239-0","article-title":"Comparison of pharmacokinetic profiles of a 17 beta-estradiol gel 0.6 mg\/g (Gelestra) with a transdermal delivery system (Estraderm TTS 50) in postmenopausal women at steady state","volume":"40","author":"Paoletti","year":"2001","journal-title":"Maturitas"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib110","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF03190030","article-title":"Pulsed estrogen therapy: pharmacokinetics of intranasal 17-beta-estradiol (S21400) in postmenopausal women and comparison with oral and transdermal formulations","volume":"24","author":"Devissaguet","year":"1999","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib111","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1001\/jama.1994.03510370051031","article-title":"Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial","volume":"271","author":"Schaefer","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib112","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1001\/jama.283.14.1845","article-title":"Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause","volume":"283","author":"Shlipak","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0021-9150(90)90177-K","article-title":"Lipoprotein(a): structure, properties and possible involvement in thrombogenesis and atherogenesis","volume":"85","author":"MBewu","year":"1990","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib114","doi-asserted-by":"crossref","first-page":"23260","DOI":"10.1074\/jbc.M302780200","article-title":"Inhibition of plasminogen activation by lipoprotein(a): critical domains in apolipoprotein(a) and mechanism of inhibition on fibrin and degraded fibrin surfaces","volume":"278","author":"Hancock","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib115","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1093\/clinchem\/37.11.1950","article-title":"Relationship of lipoprotein(a) to variables of coagulation and fibrinolysis in a healthy population","volume":"37","author":"Heinrich","year":"1991","journal-title":"Clin Chem"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib116","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S0029-7844(96)00349-3","article-title":"Lipoprotein(a) and other lipids after oophorectomy and estrogen replacement therapy","volume":"88","author":"Bruschi","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib117","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jama.1995.03530130055028","article-title":"A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes","volume":"274","author":"Boushey","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib118","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1161\/01.ATV.19.8.1899","article-title":"Dysfunction of nitric oxide mediation in isolated rat arterioles with methionine diet-induced hyperhomocysteinemia","volume":"19","author":"Ungvari","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib119","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1055\/s-2000-8472","article-title":"Hyperhomocysteinemia, vascular pathology, and endothelial dysfunction","volume":"26","author":"van Guldener","year":"2000","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib120","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/01.GME.0000079220.19081.58","article-title":"Homocysteine impairs estrogen-induced vasodilation in isolated rat arterioles","volume":"11","author":"Smolders","year":"2004","journal-title":"Menopause"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib121","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1365-2362.1995.tb01687.x","article-title":"Plasma homocysteine and menopausal status","volume":"25","author":"Wouters","year":"1995","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib122","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0021-9150(99)00321-4","article-title":"Increased plasma homocysteine after menopause","volume":"149","author":"Hak","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib123","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2013an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib124","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1161\/01.CIR.96.12.4219","article-title":"Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study","volume":"96","author":"Hwang","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib125","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/01.CIR.98.8.731","article-title":"Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women","volume":"98","author":"Ridker","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib126","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0140-6736(97)09032-6","article-title":"Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men","volume":"351","author":"Ridker","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib127","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0049-3848(00)00382-0","article-title":"Association of circulating cellular adhesion molecules with menopausal status and hormone replacement therapy. Time-dependent change in transdermal, but not oral estrogen users","volume":"101","author":"Oger","year":"2001","journal-title":"Thromb Res"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib128","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0015-0282(01)03225-3","article-title":"Effects of transdermal hormone replacement therapy on levels of soluble P- and E-selectin in postmenopausal healthy women","volume":"77","author":"Farzati","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib129","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1161\/01.CIR.102.18.2165","article-title":"Direct proinflammatory effect of C-reactive protein on human endothelial cells","volume":"102","author":"Pasceri","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib130","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1161\/01.CIR.95.1.97","article-title":"C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction","volume":"95","author":"Lagrand","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib131","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1161\/01.ATV.0000169644.88847.28","article-title":"CRP or not CRP? That is the question","volume":"25","author":"Pepys","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib132","doi-asserted-by":"crossref","first-page":"44S","DOI":"10.1016\/S0895-7061(01)02069-6","article-title":"Adhesion molecules and their role in vascular disease","volume":"14","author":"Krieglstein","year":"2001","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib133","doi-asserted-by":"crossref","first-page":"83S","DOI":"10.1016\/S0895-7061(01)02074-X","article-title":"Role of endothelin-1 in hypertension and vascular disease","volume":"14","author":"Schiffrin","year":"2001","journal-title":"Am J Hypertens"},{"issue":"Suppl 12","key":"10.1016\/j.fertnstert.2007.07.1298_bib134","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1097\/00005344-199204002-00018","article-title":"Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis","volume":"20","author":"Vallance","year":"1992","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib135","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(01)07184-7","article-title":"Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine","volume":"358","author":"Valkonen","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib136","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0140-6736(01)07217-8","article-title":"Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study","volume":"358","author":"Zoccali","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib137","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1365-2362.2005.01561.x","article-title":"Determination of a reference value for N(G), N(G)-dimethyl-L-arginine in 500 subjects","volume":"35","author":"Schulze","year":"2005","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib138","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(98)10266-0","article-title":"Venous thrombosis: a multicausal disease","volume":"353","author":"Rosendaal","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib139","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2141.1990.tb02541.x","article-title":"Antithrombin III and procoagulant activity: sex differences and effects of the menopause","volume":"74","author":"Meade","year":"1990","journal-title":"Br J Haematol"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib140","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(05)80081-9","article-title":"Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study","volume":"342","author":"Koster","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib141","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/369064a0","article-title":"Mutation in blood coagulation factor V associated with resistance to activated protein C","volume":"369","author":"Bertina","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib142","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-0037-1613145","article-title":"Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance test","volume":"88","author":"Curvers","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib143","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1016\/S0140-6736(99)06092-4","article-title":"Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study","volume":"354","author":"Rosing","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib144","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1073\/pnas.90.3.1004","article-title":"Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C","volume":"90","author":"Dahlb\u00e4ck","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib145","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1016\/S0140-6736(05)75086-8","article-title":"Acquired activated protein-C resistance","volume":"353","author":"Kluft","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib146","doi-asserted-by":"crossref","first-page":"265","DOI":"10.7326\/0003-4819-125-4-199608150-00002","article-title":"Reduced response to activated protein C is associated with increased risk for cerebrovascular disease","volume":"125","author":"van der Bom","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib147","first-page":"465","article-title":"High plasma concentration of factor VIII coagulant is also a risk factor for venous thromboembolism in the elderly","volume":"88","author":"Oger","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib148","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(86)90111-X","article-title":"Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study","volume":"2","author":"Meade","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib149","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJM199503093321003","article-title":"Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group","volume":"332","author":"Thompson","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib150","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0021-9150(97)00081-6","article-title":"Von Willebrand factor and soluble E-selectin in the prediction of cardiovascular disease progression in hyperlipidaemia","volume":"132","author":"Blann","year":"1997","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib151","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1055\/s-0037-1612974","article-title":"Factor VII activity is an independent predictor of cardiovascular mortality in elderly women of a Sicilian population: results of an 11-year follow-up","volume":"87","author":"Noto","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib152","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1055\/s-0038-1649632","article-title":"Haemostatic variables and menopausal status: influence of hormone replacement therapy","volume":"70","author":"Scarabin","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib153","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1161\/01.ATV.16.9.1170","article-title":"Population correlates of coagulation factor VII. Importance of age, sex, and menopausal status as determinants of activated factor VII","volume":"16","author":"Scarabin","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"Suppl 16","key":"10.1016\/j.fertnstert.2007.07.1298_bib154","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1471-0528.1997.tb11565.x","article-title":"The effects of transdermal oestradiol and oral progestogens on haemostasis variables","volume":"104","author":"Kroon","year":"1997","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib155","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1055\/s-0038-1655951","article-title":"Coagulation activation markers in the prediction of venous thrombosis after elective hip surgery","volume":"77","author":"Cofrancesco","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib156","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1161\/01.CIR.98.21.2241","article-title":"High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor","volume":"98","author":"Th\u00f6gersen","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib157","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1161\/01.CIR.91.7.1952","article-title":"Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring Study","volume":"91","author":"Gebara","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib158","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1001\/jama.295.6.655","article-title":"Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial","volume":"295","author":"Howard","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib159","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1177\/106002809402800310","article-title":"Lipoprotein(a): physiologic function, association with atherosclerosis, and effects of lipid-lowering drug therapy","volume":"28","author":"Spinler","year":"1994","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib160","first-page":"339","article-title":"Estrogens, homocysteine, vasodilatation and menopause: basic mechanisms, interactions and clinical implications","volume":"17","author":"Smolders","year":"2003","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib161","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1210\/jc.2002-021929","article-title":"New markers for cardiovascular disease risk in women: impact of endogenous estrogen status and exogenous postmenopausal hormone therapy","volume":"88","author":"Davison","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib162","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1089\/jwh.2006.15.35","article-title":"Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation","volume":"15","author":"Grodstein","year":"2006","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib163","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/jama.297.13.1465","article-title":"Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause","volume":"297","author":"Rossouw","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib164","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/01.CIR.92.1.24","article-title":"17 beta-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease","volume":"92","author":"Collins","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib165","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1056\/NEJM200008243430801","article-title":"Effects of estrogen replacement on the progression of coronary-artery atherosclerosis","volume":"343","author":"Herrington","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib166","first-page":"61","article-title":"The new conundrum: do estrogens have any cardiovascular benefits?","volume":"47","author":"Clarkson","year":"2002","journal-title":"Int J Fertil Womens Med"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib167","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.fertnstert.2004.11.012","article-title":"Postmenopausal hormone therapy: critical reappraisal and a unified hypothesis","volume":"83","author":"Phillips","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib168","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1161\/01.ATV.0000133683.65877.bc","article-title":"Effects of conventional or lower doses of hormone replacement therapy in postmenopausal women","volume":"24","author":"Koh","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib169","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/gerona\/59.8.M827","article-title":"The effect of different doses of micronized 17beta-estradiol on C-reactive protein, interleukin-6, and lipids in older women","volume":"59","author":"Prestwood","year":"2004","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib170","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/01.ATV.0000115383.49802.0c","article-title":"Effect of lower dosage of oral conjugated equine estrogen on inflammatory markers and endothelial function in healthy postmenopausal women","volume":"24","author":"Wakatsuki","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib171","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1136\/jech.46.3.261","article-title":"Seasonal variation in mortality in The Netherlands","volume":"46","author":"Mackenbach","year":"1992","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib172","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0735-1097(98)00098-9","article-title":"Seasonal distribution of acute myocardial infarction in the second National Registry of Myocardial Infarction","volume":"31","author":"Spencer","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib173","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0140-6736(94)92689-1","article-title":"Seasonal variations of plasma fibrinogen and factor VII activity in the elderly: winter infections and death from cardiovascular disease","volume":"343","author":"Woodhouse","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib174","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1161\/01.ATV.17.11.2692","article-title":"Seasonal variations of rheological and hemostatic parameters and acute-phase reactants in young, healthy subjects","volume":"17","author":"Frohlich","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib175","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/00001721-200107000-00004","article-title":"Seasonal variation of some metabolic and haemostatic risk factors in subjects with and without coronary artery disease","volume":"12","author":"Mavri","year":"2001","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib176","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ijcard.2005.03.045","article-title":"Seasonal variation of C-reactive protein in apparently healthy Koreans","volume":"107","author":"Sung","year":"2006","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib177","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib178","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/jama.279.20.1615","article-title":"Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS\/TexCAPS. Air Force\/Texas Coronary Atherosclerosis Prevention Study","volume":"279","author":"Downs","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.fertnstert.2007.07.1298_bib179","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/0002-9378(90)90048-C","article-title":"Consensus Development Meeting: Metabolic aspects of oral contraceptives of relevance for cardiovascular diseases","volume":"162","author":"Gaspard","year":"1990","journal-title":"Am J Obstet Gynecol"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028207015427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028207015427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T07:28:24Z","timestamp":1758007704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028207015427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":179,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0015028207015427"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2007.07.1298","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of non-oral postmenopausal hormone therapy on markers of cardiovascular risk: a systematic review","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2007.07.1298","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}